Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $456.29 | 12 | 89.7% |
| Education | $52.65 | 2 | 10.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $239.58 | 8 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $72.67 | 1 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $62.73 | 1 | $0 (2022) |
| Shionogi Inc | $56.57 | 1 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $39.95 | 1 | $0 (2024) |
| PFIZER INC. | $24.74 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $12.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $155.88 | 6 | Gilead Sciences, Inc. ($115.93) |
| 2023 | $101.56 | 2 | Gilead Sciences, Inc. ($101.56) |
| 2022 | $157.49 | 3 | Janssen Scientific Affairs, LLC ($72.67) |
| 2019 | $94.01 | 3 | Shionogi Inc ($56.57) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.23 | General |
| 09/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.47 | General |
| 05/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Education | In-kind items and services | $39.95 | General |
| Category: ANTIBIOTIC | ||||||
| 05/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.30 | General |
| 04/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.04 | General |
| 03/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.89 | General |
| 10/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $79.87 | General |
| 10/12/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.69 | General |
| 10/20/2022 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $62.73 | General |
| 10/19/2022 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $72.67 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/29/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.09 | General |
| 11/06/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/02/2019 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $56.57 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/03/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 133 | 170 | $35,822 | $13,721 |
| 2022 | 5 | 187 | 254 | $50,710 | $19,685 |
| 2021 | 8 | 268 | 356 | $65,091 | $25,602 |
| 2020 | 5 | 173 | 238 | $40,844 | $15,478 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 42 | $9,038 | $3,859 | 42.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $11,396 | $3,616 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 33 | $4,848 | $2,060 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 22 | $4,627 | $2,028 | 43.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $5,626 | $1,947 | 34.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 25 | $287.00 | $210.00 | 73.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 50 | $20,350 | $7,530 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 65 | $13,585 | $5,743 | 42.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 43 | $9,202 | $3,405 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 49 | $7,056 | $2,869 | 40.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 29 | 47 | $517.00 | $139.14 | 26.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 43 | 43 | $17,501 | $6,498 | 37.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 72 | $15,408 | $5,704 | 37.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 79 | $11,376 | $4,437 | 39.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 41 | $8,569 | $4,066 | 47.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $5,540 | $2,083 | 37.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $3,372 | $1,664 | 49.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 17 | $2,533 | $936.87 | 37.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 40 | 72 | $792.00 | $213.15 | 26.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 35 | 35 | $13,867 | $5,485 | 39.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 98 | $13,974 | $4,894 | 35.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 32 | 44 | $8,972 | $3,571 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 18 | $3,718 | $1,400 | 37.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 26 | 43 | $313.00 | $127.98 | 40.9% |
About Dr. Edwin Hayes, M.D
Dr. Edwin Hayes, M.D is a Infectious Disease healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2013. The National Provider Identifier (NPI) number assigned to this provider is 1942543632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edwin Hayes, M.D has received a total of $508.94 in payments from pharmaceutical and medical device companies, with $155.88 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($456.29).
As a Medicare-enrolled provider, Hayes has provided services to 761 Medicare beneficiaries, totaling 1,018 services with total Medicare billing of $74,486. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Columbia, SC
- Active Since 04/01/2013
- Last Updated 09/10/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942543632
Products in Payments
- SYMTUZA (Drug) $72.67
- Fetroja (Drug) $56.57
- NUZYRA (Drug) $39.95
- PREVNAR - 13 (Biological) $24.74
- ZERBAXA (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Columbia
Dr. Phillip Beck, M.d, M.D
Infectious Disease — Payments: $5,742
Dr. Robert Ross, M.d, M.D
Infectious Disease — Payments: $3,320
Dr. Eric Brener, M.d, M.D
Infectious Disease — Payments: $2,753
Harmeet Gill, Md, MD
Infectious Disease — Payments: $1,836
Pamela Bailey
Infectious Disease — Payments: $1,451
Amy Bowers, Do, DO
Infectious Disease — Payments: $1,227